top of page
  • LinkedIn

Funding

We have listed below some of the key funding calls (mainly grants) that are applicable to companies in UK healthcare. For more information, please contact us.

Past funding calls can be viewed using these links:

2026

2025

2024

Upcoming Funding Calls
i4i THRIVE - March 2026

Funder: NIHR

Opens: 12 March 2026

Closes: 1pm, 17 April 2026

Sector: Healthcare & Life Sciences

​The Invention for Innovation (i4i) THRIVE (Translate Healthcare Research through InnoVation and Entrepreneurship) funding and training programme funds early stage innovations which tackle health inequalities. This is a full researcher-led funding opportunity. 
 

THRIVE supports clinicians and researchers to accelerate the translation of healthcare innovations tackling health inequalities from bench to bed, speed up patient benefit and concurrently expand the entrepreneurial mindset of researchers and clinicians.
 

THRIVE offers up to £150,000 over 9 months to support the development of a technology-based product or service, and a structured programme of entrepreneurial training, mentoring, peer support and networking. Through the programme the innovators will explore the market for their innovation and identify potential routes for commercialising (spin-out vs licensing) or sustaining their innovation (Intrapreneurship) and leave the programme with a plan to achieve their goals, a network of support and with the skills for the next steps of commercialisation.

More information here.

Prosperity Partnerships 2027

Funder: EPSRC

Open: TBC

Closes: TBC

Sector: ALL

The EPSRC Prosperity Partnerships 2027 funding call supports ambitious, collaborative research programmes designed to create long-term prosperity for the UK through business-led innovation. The scheme specifically targets projects that will catalyse lasting benefits, such as job and revenue growth or the tackling of broad societal and sustainability challenges.​
 

Scope

  • Proposals must be for substantial, collaborative research partnerships between businesses and academic institutions.​

  • The projects must be co-created and co-delivered by both types of partners, with a strong focus on delivering impact that is aligned with UK priorities.​


Eligibility

  • Projects must be business-led and involve one or more academic partners.​

  • Both business and academic partners must play significant roles in shaping and delivering the work.​

  • The business partner’s cash contribution must at least match the amount funded by EPSRC.​


Process, Value & Timings

  • EPSRC will fund up to 80% of the full economic cost (FEC) of the academic portion of the project.​

  • The business cash contribution is required to match the EPSRC funding, ensuring substantial co-investment from the private sector.​

  • This is a pre-announcement; the full call details and application guidance will be published in early February 2026.​

  • A pre-announcement webinar is scheduled for 9 December 2025 for potential applicants interested in learning more about the call.​

This scheme is designed to foster large-scale, sustainable business–academic collaboration aligned with national prosperity and innovation goals.
More information here.

Current Funding Calls
Work and Health Research Awards Round 2

Funder: NIHR

Opened: 12 June 2025

Closes: 1pm, 11 March 2026

Sector: Healthcare & Life Sciences

The National Institute for Health and Care Research (NIHR) invites applications for work and health research awards. The purpose of these awards is to enable research teams to receive funding for larger programmes of research or large scale and ambitious projects to tackle priorities in work and health research. These awards can cost up to £2 million over 3 years. 

This competition aims to:

  • bring together teams representing different disciplines, professions and sectors to submit plans for ambitious research and to catalyse future research capacity; 

  • fund large scale, ambitious and transdisciplinary projects or programmes of research addressing key priorities and substantial areas of need in work and health and occupational health. 

More information here.

Gap Fund: single-step support for medical product development

Funder: MRC

Opened: 13 November 2025 

Closes: 4pm, 11 March 2026

Sector: Life Sciences

The MRC Gap Fund provides targeted, single-step support for researchers developing a new or repurposed medicine, medical device, diagnostic, or other medical product. The fund enables projects to address a high-risk development milestone, helping to generate critical data needed to advance or end a product’s development. It acts as a strategic bridge between the MRC’s smaller Impact Acceleration Account (IAA) and the larger Developmental Pathway Funding Scheme (DPFS).

​

Eligibility:

Applicants must be based at an MRC-eligible UK research organisation.

​

Funding covers:

  • Key high-risk development steps

  • Activities to generate data essential for onward progression or decision-making

​

The Gap Fund supports MRC’s strategic priorities including:

  • precision prevention to reduce disease risk in targeted populations

  • early and accurate diagnosis to improve speed and accuracy of disease detection

  • advanced treatments offering novel therapeutic approaches

  • improve outcome monitoring of patients receiving treatment

  • better management of diseases and conditions through innovative technologies
     

All human diseases and medical interventions are eligible for support, both in the context of UK healthcare and addressing global health issues.

 

For full details and guidance on how to apply, visit the official call here.

Genomics in Context Awards

Funder: Wellcome

Open

Closes: 16 March 2026

Sector: Genomics

The Wellcome Genomics in Context Awards fund interdisciplinary and transdisciplinary research teams exploring genomics in combination with the humanities, social sciences, or bioethics. Projects must build novel collaborations and shape new research agendas at the intersection of genomics and its wider contexts, with stakeholder involvement encouraged throughout.

 

Teams should include at least one researcher from the life sciences, one from the humanities/social sciences/bioethics, and one wider stakeholder, and may be based anywhere in the world except mainland China.

​

Eligibility:

  • Lead applicant must hold a PhD or equivalent and be based at an eligible institution.

  • Teams must include 1–4 coapplicants from relevant disciplines and a wider key stakeholder.

 

Funding covers:

  • Up to £500,000 per award for 12–24 months.

  • Research costs, collaborative activities, stakeholder involvement, and dissemination.

 

The scheme seeks creative approaches to co-leadership and emphasises equity, engaged research, and the co-development of discovery-led research agendas. For full details and application guidance, see the official call here.

Scaling Impact in Health and Care Fund

Funder: Sir Jules Thorn Charitable Trust

Open 

Closes: 12pm, 16 March 2026

Sector: Health and care

The Scaling Impact in Health and Care Fund supports charities and NHS organisations to expand proven health and care interventions and deliver them more widely. The Fund focuses on projects underpinned by real-world evidence of effectiveness, with strong potential for adoption and integration at scale. It prioritises initiatives that can demonstrate sustainability, system-level benefit, and measurable improvements for people and services. It is a two stage process. this is the first stage.

​

Previously known as the Innovation and Improvement in Health and Care Fund, it was refined in 2025 to better reflect its focus on bridging the gap between models of care that have been shown to work in practice and securing the resources needed to deliver them at scale.

​

The Fund makes awards between £150,000 and £500,000, with successful applicants required to draw down the funding within two years of the award date.

Applications may address any area of physical or mental health, physical or learning disability, or end-of-life care.

​

The Trust is seeking to fund projects that can meet all the following criteria:

  • Scale-tested models of care that have demonstrated effectiveness in real-world settings

  • Strengthen collaboration and integration across one or more care settings, including primary, secondary, or community care

  • Embed the partnerships, infrastructure, and evidence needed to sustain delivery at scale

  • Deliver practical improvements in outcomes for users, carers, and staff, and greater efficiency across services

The Fund will not support incremental service developments, funding to maintain existing services, or projects without demonstrated effectiveness or potential for wider impact.

More information here.

TechLocal: Connecting Local Talent to Local Tech Jobs

Funders: Innovate UK & DSIT

Opened: 4 February 2026

Closes: 11am, 18 March 2026 

Sector: ALL

This competition is open to collaborations only. To lead a collaborative project your organisation must be a UK registered business, research and technology organisation, charity, not for profit or public sector organisation.

​​

The aim of this competition is to develop impactful local initiatives that enable tech talent to secure entry level tech jobs by bridging the gap between training and employment.

 

Award range: £100,000 - £225,000
Total fund: £7.6m
 

Your proposal must:

  • be delivered and demonstrate impact in one or more of the specified geographic areas, addressing a local need or leveraging a local strength

  • demonstrate clear impact in one or more frontier technologies by enabling local talent into entry level tech jobs and helping SMEs adopt these technologies through skilled workforces

  • alignment with national and local economic growth plans and skills strategies, such as DWP Jobcentres, the Growth and Skills Levy, LSIPs and local defence plans

  • demonstrate contribution to the overall TechLocal target of 1,000 new tech jobs

​​

The six frontier technologies are:

  • Artificial Intelligence

  • Cyber Security

  • Engineering Biology

  • Semiconductors

  • Advanced Connectivity Technologies (ACT)

  • Quantum


The specific geographical areas are:

  • North West England

  • South West England

  • Yorkshire and Humber

  • North East England

  • East Midlands

  • West Midlands

  • South East England

  • East of England

  • London

  • Scotland

  • Wales

  • Northern Ireland

More information here.

Step-up treatment for people with uncontrolled asthma

Funder: NIHR

Opened: 4 December 2025 

Closes: 1pm, 18 March 2026

Sector: Healthcare & Life Sciences

NIHR's Health Technology Assessment (HTA) Programme is looking to fund research into step-up treatment for people with uncontrolled asthma.

​

This is a 2-stage, commissioned funding opportunity. To apply for the first stage you should submit an outline application. If invited to the second stage, you will then need to complete a full application.

​

Research question: What is the best step-up treatment for people aged 12 years and older diagnosed with asthma, whose asthma is uncontrolled on a low-dose inhaled corticosteroid/formoterol combination inhaler used as needed?

​

More information here.

Developmental pathway funding scheme: stage one

Funder: MRC

Opened: 20 November 2025

Closes: 4pm, 18 March 2026

Sector: Healthcare & Life Sciences

Apply for funding to develop and test novel therapeutics, medical devices, diagnostics and other interventions.

​

Your project can start and finish at any stage on the developmental pathway from prototype development, through pre-clinical refinement and testing to early-phase clinical studies and trials (up to phase 2a).

​

You must be based at a research organisation eligible for Medical Research Council (MRC) funding.

​

There is no limit on the amount of funding you can apply for, but it should be appropriate to the project. We usually fund 80% of a project’s full economic cost (FEC).

More information here.

Scaling Trust: Full proposals

Funder: ARIA

Open

Closes: 2pm, 24 March 2026

Sector: Gen AI

ARIA is now accepting applications for funding within its £50m Scaling Trust programme. The programme’s goal is to create the capability for AI agents to securely coordinate, negotiate, and verify with one another on our behalf. To kickstart Phase 1 of this programme, ARIA is seeking to fund teams to develop open-source coordination infrastructure and perform fundamental research that moves us from empirical to theory-driven guarantees in agentic coordination.

​

In advance of launching the Scaling Trust Arena, ARIA is looking to fund teams across the following programme tracks:
 

Track 2 | Tooling: Open-source agents and reusable components that enable secure requirement capture, negotiation, protocol generation, and verification in multi-agent settings. Must be usable by all Arena participants, built for adversarial environments, and designed to generalise beyond single tasks.
 

Track 3 | Fundamental research: Foundational work that turns empirical security into provable guarantees, and unlocks new cyber-physical trust primitives for agents. Focus areas include formal AI security, generative protocol design and verification, and cyber-physical trust anchors.


Full details of what is in and out of scope for each area can be found in the call for proposals.

More information here.​​​

Robotics Adoption Programme skills development

Funder: SIT

Opened: 2 February 2026

Closes: 11am, 25 March 2026

Sector: ALL

The Department for Science, Innovation and Technology, delivered through Innovate UK, is providing up to £2.5 million to develop vocational robotics skills courses across the UK. 

Your project must:

  • have a grant funding request of between £100,000 and £500,000

  • start by 1 August 2026

  • end by 31 January 2027

  • last between three and six months

​

Research Aims and Scope

Projects must develop vocational robotics skills courses to build the workforce needed for UK robotics adoption. This aligns with the broader Robotics Adoption Hubs programme (a £40 million initiative announced with delivery starting early 2026) which aims to enable SMEs and manufacturers to access and implement robotics technology effectively.​

​

Lead Organisation Eligibility

UK registered organisations can lead applications. This includes universities, businesses, and public sector organisations, reflecting a broad-based approach to skills development across different institutional types.​

​

Project Scope and Opportunities

Projects can develop multiple types of skills initiatives to address the critical workforce gap in robotics adoption. Opportunities include but are not limited to:​

  • Apprenticeships and internships

  • Upskilling and reskilling of existing workforce

  • Technical courses and training programmes

  • Vocational qualifications aligned to industry needs

More information here.

Early Detection and Diagnosis Primer Award

Funder: Cancer Research UK

Open: 

Closes: 26 March 2026

This scheme aims to support new and pioneering research ideas and pilot studies of high scientific risk to stimulate and develop the early detection field. Funding is for up to £100,000 for projects lasting up to 1 year led by a scientist, clinician or healthcare worker based in a UK university, medical school, hospital or research institution. 

More information here.

Sector: Healthcare & Life Sciences

Launchpad Grants in Children & Young People's Movement and Balance disorders

Funder: MRF

Opened: 10 December 2025

Closes: 12pm, 27 March 2026

Sector: Healthcare

This scheme is designed to support research that will increase understanding of movement and balance disorders in children and young people, improve diagnosis, and develop better treatments and interventions. For the purposes of this funding scheme, the term ‘children and young people’ (CYP) refers to anyone below the age of 25.

​

Applicants may apply for up to £100,000 over a maximum of a 2-year period (pro-rata for part-time positions). There will be at least £500,000 available in this competition.
 

Research proposals are encouraged that include the following themes:

  • Increased understanding of the molecular and cellular mechanisms underlying the causes of movement disorders

  • Further understanding of mechanisms of action of any available therapies

  • Development of treatments and interventions, including pharmaceutical and non-pharmaceutical interventions (such as orthotics, splints, physiotherapy, speech and language therapies)

  • Mental health impacts of movement and balance disorders in children and young people

More information here.

Discovery Awards

Funder: Wellcome

Open

Closes: 31 March 2026

Sector: Healthcare & Life Sciences

This scheme provides funding for established researchers and teams from any discipline who want to pursue bold and creative research ideas to deliver significant shifts in understanding related to human life, health and wellbeing. Maximum grant of £5m over a maximum duration of up to 8 years.

​

The lead organisation must be a not-for-profit and can be a:

  • higher education institution

  • research institute

  • healthcare organisation

  • charity or social enterprise

​

Your research must:


Your research can:

  • be in any discipline - including science, technology, engineering and mathematics (STEM), experimental medicine, humanities and social science, clinical/allied health sciences, and public health

  • be in a single discipline or multidisciplinary.
     

Your research must not:

  • fall outside of what Wellcome support in Discovery Research. Check what Wellcome don't fund.

  • start earlier than seven months after the application deadline.

​

More information here.

Knowledge Transfer Partnership: 2026 to 2027 round one

Funder: Innovate UK

Opened: 2 February 2026

Closes: 11am, 1 April 2026

Sector: ALL

The Knowledge Transfer Partnership (KTP) programme allows a UK registered business, which is referred to as the business partner from now on, to partner with a knowledge base partner. This can be either a UK higher education (HE) or further education (FE) institution, research and technology organisation (RTO) or Catapult.

​

The KTP partnership brings new skills and the latest academic thinking into the business partner to deliver a specific, strategic innovation project. The knowledge base partner recruits the associate to work on the project. The associate has the opportunity to lead a strategic development within the business, developing new skills and gaining valuable experience.

​

Each application must be led by a knowledge base, working with a business partner and supported by a Knowledge Transfer Adviser. If you are a business and do not yet have a relationship with a knowledge base partner, the Knowledge Transfer Adviser can help you to identify one.

​

A project’s total eligible costs are typically £8,500 per month. Projects must be between 12 and 36 months. Some of the knowledge base partners costs will be funded by Innovate UK. The rest of the eligible project costs are paid by the business partner.

More information here.

NICE rolling funding opportunity (EME Programme)

Funder: NIHR

Opened: 3 December 2025

Closes: 1pm, 1 April 2026

Sector: Healthcare & Life Sciences

The Efficacy and Mechanism Evaluation (EME) Programme is inviting outline applications to their commissioned workstream. NIHR is interested in receiving applications to meet recommendations in research identified in NICE guidance that has been published or updated in the last 5 years.  
 

Applications must be within the remit of the EME Programme and the primary outcome measure must be health related. This funding opportunity is also open in the following:

which fall within the remit of those programmes. Applicants should apply directly to the relevant programme.

​

This is a 2-stage funding opportunity. To apply for the first stage you should submit an outline application. If invited to the second stage, you will then need to complete a full application.

More information here.

​

RfPB Under-represented disciplines and specialisms: Nurses and Midwives 2025/26

Funder: NIHR

Opened: 19 November 2025

Closes: 1pm, 8 April 2026

Sector: Healthcare & Life Sciences

This Research for Patient Benefit (RfPB) funding opportunity is part of ring-fenced funding in support of the NIHR strategy to strengthen the careers of under-represented disciplines and specialisms in health and care professions.

 

Applicants must submit an expression of interest form by 2 March 2026

​

To support capacity building, all applications to this funding opportunity must be led by a nurse or a midwife at an early stage of their research career. For this funding opportunity, an early career researcher is a researcher who has not yet been the lead investigator for a substantial project award (>£100,000). 

​

The early career nurse or midwife is expected to apply as lead applicant supported by a senior colleague fulfilling the role as joint-lead applicant. The joint-lead mentor can have any relevant professional background as long as they are experienced researchers in a field relevant to the proposed research. The mentor is expected to have led at least one large research project (at a value of >£100,000) to completion and have relevant experience of mentoring an early career researcher.

​

The RfPB programme is researcher-led and does not specify topics for research, so applications can be primary, secondary and include quantitative, qualitative and mixed methods designs. The topic of the projects funded in the previous funding opportunity supporting nurses and midwives can be found in the news story on the website.

​

More information here.

​Quarterly Research Grant Funding Programme

Funder: Cure Parkinson's

Open: 

Closes: 13 April 2026 

Sector: Healthcare

This scheme is providing grants for scientists and clinicians from universities, hospitals and commercial organisations to help them fund preclinical and clinical research focused on slowing, stopping, or reversing Parkinson’s.

​

There are grants of up to £250,000 which prioritise projects that are likely to lead to clinical trials in people with Parkinson’s within 5 years. For clinical research, CP funds clinical trials and sub-studies of trials in people with Parkinson’s. The grant amount is flexible but please contact CP ahead of submission if you are thinking of applying for a clinical trial.

​

2025/2026 application deadlines:

  • Monday 3 November 2025

  • Monday 12 January 2026

  • Monday 13 April 2026

  • Monday 22 June 2026

  • Monday 12 October 2026

More information here.

Contracts for Innovation: industrial human relevant drug models

Funder: Innovate UK

Opened: 2 March 2026

Closes: 11am, 15 April 2026

Sector: Life Sciences

This competition is part of the Innovate UK Alternative Industrialised Models for ethical Drug Discovery (AIM) programme and is delivered in partnership with the National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs).
 

The aim of the competition is to support organisations developing disruptive and innovative alternatives for improved pharmacokinetic (PK) and cardiac safety studies to:

  • further qualify the methods towards broad adoption

  • or improve their applicability in a drug development setting


Your project must focus on developing new approaches or further developing existing approaches that can be deployed within a drug development setting. It must enable progress towards the government targets of:

  • more than 35% reduction in dedicated PK studies using dogs or non-human primates (NHPs)

  • more than 50% reduction in dedicated cardiovascular safety studies using dogs or NHPs by 2030

 

This is phase 1 of a potential 2 phase competition. In applying to phase 1 of this competition you are entering into a competitive process. This competition has a funding budget of up to £2 million, so Innovate UK may not be able to fund all the proposed projects.Phase 1 projects can range in size up to total eligible costs of £200,000, inclusive of VAT.

More information here.

Digital cluster call 1

Funder: Horizon (EU)

Opened: 15 January 2026

Closes: 15 April 2026

Sector: Digital (ALL)

The expected impacts of this cluster are contained in the Horizon Europe strategic plan.

Areas of intervention

  • manufacturing technologies

  • key digital technologies including quantum technologies

  • emerging enabling technologies

  • advanced materials

  • artificial intelligence and robotics

  • next generation internet

  • advanced computing and Big Data

  • circular industries

  • low carbon and clean industries

  • space including earth observation

​

The destinations within this call are as follows:

  • Developing an agile and secure single market and infrastructure for data-services and trustworthy artificial intelligence services.

  • Achieving open strategic autonomy in digital and emerging enabling technologies

  • Digital and industrial technologies driving human-centric innovation

​

Total funding available is 222 million Euros.

​

See more information and apply here.​​

Experimental medicine stage one

Funder: MRC

Opened: 2 October 2025

Closes: 4pm, 15 April 2026

Sector: Life Sciences

Apply for funding to investigate the causes, progression and treatment of human disease.

Your project must:

  • focus on a mechanistic hypothesis

  • include an experimental intervention or challenge in humans

 

You must be a researcher based at a research organisation eligible to apply for MRC funding. If you are taking the next step towards becoming an independent researcher, you may be eligible to apply as a ‘new investigator.

​

There is no limit to the amount of funding you can apply for (Total fund is £10m) or the length of your project. The MRC will fund 80% of your project’s full economic cost.

​

This is an ongoing funding opportunity. Application rounds close every April and October.

More information here.

Robotics adoption hubs

Funder: Innovate UK

Opened: 24 February 2026

Closes: 11am, 15 April 2026

Sector: ALL

UK registered organisations can apply for a share of up to £38 million for creating one-stop shops to help end-users adopt robotics and autonomous systems with expert guidance. For this competition, robotics is defined broadly. It includes drones operating on land, sea and air; autonomous plant and service robots; and industrial robots or automated machinery that use sensors, actuators and control software. Robotics does not include systems that are only software based.

​

The aim of this competition is to bridge the knowledge gap to impact productivity, safety and growth, and deliver public benefit through accelerating adoption of robotics. â€‹Your project’s total eligible grant funding request must be between £2 million and £7.5 million.

​

Hubs will be located within a region, may have single or multi end user sector focus and are expected to build on strengths and capabilities within the existing ecosystem.
​

Hubs will at a minimum:

  • advise end users on robotics benefits, costs and integration needs, help identify applications, and connect them with vendors, integrators and finance providers

  • showcase robotics technologies and capabilities at the Hub and in representative environments

  • build in a mechanism to be self sustaining beyond the end of the programme

  • work with the central convening body to share lessons learned, develop national adoption resources, and triage enquiries to the most suitable Hub

  • focus on adoption led activity rather than low Technology Readiness Level (TRL) or fundamental research

  • reuse existing facilities rather than building new or significantly refurbishing physical infrastructure

  • purchase limited robotic demonstration equipment for showcasing, with primary use of existing hardware

More information here.

Enhancing and enlarging the European Partnership on Personalised Medicine

Funder: Horizon Europe

Opened: 10 February 2026

Closes: 5pm (CET), 16 April 2026

Sector: Life Sciences

This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination “Ensuring equal access to innovative, sustainable, and high-quality healthcare”. To that end, proposals under this topic should aim to deliver results that are directed at, tailored towards and contributing to all the following expected outcomes:

  • European countries and regions, along with international partners, are engaged in enhanced collaborative research efforts for the development of innovative personalised medicine approaches regarding prevention, diagnosis and treatment.

  • Healthcare authorities, policymakers and other stakeholders develop evidence-based strategies and policies for the uptake of personalised medicine in national or regional healthcare systems.

  • Health industries, policymakers and other stakeholders have access to efficient measures and investments to allow swift transfer of research and innovation into market.

  • Health industries and other stakeholders can accelerate the uptake of personalised medicine through the adoption of innovative business models.

  • Healthcare authorities, policymakers and other stakeholders use improved knowledge and understanding of the health and costs benefits of personalised medicine to optimise healthcare and make healthcare systems more sustainable.

  • Healthcare providers and professionals improve health outcomes, prevent diseases and maintain population health through the implementation of personalised medicine.

  • Stronger and highly connected local/regional ecosystems of stakeholders, including innovators, are in place and facilitate the uptake of successful innovations in personalised medicine, thus improving healthcare outcomes and strengthening European competitiveness.

  • Citizens, patients and healthcare professionals have a better knowledge of personalised medicine and are better involved in its implementation.

  • Stakeholders cooperate better and establish a network of national and regional knowledge hubs for personalised medicine.

More information here.

Veterans' health

Funder: NIHR

Opened: 15 July 2025

Closes: 1pm, 21 April 2026

Sector: Healthcare & Life Sciences

This scheme aims to support research which evaluates the effects of interventions on the mental, physical, or both aspects of Veterans' health.

 

NIHR is seeking research that evaluates interventions which can have an impact on the mental and physical health outcomes of veterans through community-based public health approaches. This can include both targeted, small-scale initiatives and larger community-level strategies that enhance access to health and well-being services for veterans, as well as other policy decisions in areas outside of health that may impact health. NIHR is particularly interested in interventions that address key barriers to healthcare access, promote early intervention, and support veterans' transition to civilian life.

 

Evaluations should clearly define the nature of the intervention from the outset, avoiding broad generalisations and ensuring a precise understanding of the mechanisms at play.

More information here.

Men’s mental health

Funder: NIHR

Opened: 15 July 2025

Closes: 1pm, 21 April 2026

Sector: Healthcare

​​NIHR's Public Health Research (PHR) Programme is looking to fund research which evaluates the health and health inequality impacts of interventions aimed at promoting good mental health or preventing poor mental health among men.

This is a 2-stage funding opportunity. To apply for the first stage you should submit an outline application. If invited to the second stage, you will then need to complete a full application.

​

Research question: What are the health and health inequality impacts of interventions aimed at promoting good mental health or preventing poor mental health among men?

​

This funding opportunity focuses on research evaluating mental health interventions (excluding individual-level mental health treatments) for men at different stages of the life-course. NIHR's Public Health Research (PHR) Programme prioritises interventions at a population or group level, rather than individual interventions, with a focus on addressing health inequalities and the wider determinants of health. 

​

Suggested research areas include, but are not limited to, evaluations of:

  • interventions that utilise lifestyle behaviours or changes to improve men’s mental health

  • community-based interventions

  • programmes adopting a whole-community approach to men’s mental health. This could include interventions:

  • based in specific settings, such as schools, colleges, universities, workplaces, leisure venues, places of worship, community groups and services, health centres, or criminal justice settings

  • focused on specific population groups, such as men from particular ethnic minority groups, men from sexual and gender minorities, or men experiencing different forms of disadvantage

  • for which the primary focus of the intervention is not necessarily on improving mental health, but the activity or mechanism might impact mental health (positively or negatively)

  • interventions that address the multiple, interacting disadvantages affecting the most marginalised men

  • trauma-informed and trauma-specific interventions

  • interventions or initiatives aimed at proactively addressing help seeking behaviour among men at risk of perpetrating violence and their impact on mental health

  • interventions related to the influence of societal and cultural norms, gender roles and beliefs across diverse male populations

  • evaluation of public health campaigns and educational initiatives designed to challenge harmful gender stereotypes and to support healthy relationships

  • intergenerational interventions

  • Interventions that take a holistic, person-centred approach

  • peer support interventions

  • interventions related to social media, or online images, messages, or digital content

  • the impact of drugs and alcohol

More information here.

​NICE rolling funding opportunity (PHR Programme)

Funder: NIHR

Opened: 16 December 2025

Closes: 1pm, 21 April 2026

Sector: Healthcare & Life Sciences

​The Public Health Research (PHR) Programme is inviting outline applications via the commissioned workstream. NIHR is interested in receiving applications to meet recommendations in research identified in NICE guidance that has been published or updated in the last 5 years.   
 

Applications must be within the remit of the PHR Programme, and the primary outcome measure must be health related. The following research programmes are also participating in this funding opportunity: 


After checking the programme remit, you should apply directly to the relevant programme funding opportunity.
 

This is a 2-stage funding opportunity. To apply for the first stage you should submit an outline application. If invited to the second stage, you will then need to complete a full application.

More information here.

James Lind Alliance Priority Setting Partnerships rolling funding opportunity (PHR Programme)

Funder: NIHR

Opened: 16 December 2025

Closes: 1pm, 21 April 2026

Sector: Healthcare & Life Sciences

​​The JLA Priority Setting Partnerships facilitate patients, carers and clinicians to work collaboratively to identify research priorities in particular areas of health and care. The Public Health Research (PHR) Programme is inviting outline applications to its commissioned workstream.

​

Write a maximum of 5 A4  pages for your research plan. When reviewing applications, NIHR will not consider any additional information over this 5 page limit.
 

Applicants should clearly state how their proposed research addresses a current evidence gap and how the research adds value to the existing NIHR research portfolio.

​

The top 10 priorities (for multiple years and countries) of the JLA priority setting partnerships are shown here. 2025 priorities include:

  • Bone marrow transplantation in paediatrics

  • Burn injury

  • Co-existing dementia and hearing conditions

  • Diverticular disease

  • East London Pandemic PSP for Ethnic Minority Communities

  • Epidermolysis Bullosa

  • Faecal Incontinence in Adults

  • Mental Health and the Body Clock

  • Midwifery Practice and Maternity Care

  • Palliative and End of Life Care Refresh

  • Perianal Crohn’s Disease

  • Prehabilitation for Hip & Knee Replacement Surgery

  • Premature Babies born <25 weeks' gestation

More information here.

Innovative Health Initiative 12th Call For Proposals

Funder: Horizon Europe

Opened: 21 January 2026

Closes: 21 April 2026

Sector: Healthcare

​International consortia can apply for this single-stage funding to support projects to tackle unmet public health needs with ambitious public-private partnerships. Topics within the call include, but are not limited to, boosting innovation for a better understanding of the determinants of health and boosting innovation through better integration of fragmented health R&I efforts.

​

The call contains five topics, each focusing on one of the five IHI Specific Objectives (SOs) as set out in the Strategic Research and Innovation Agenda (SRIA): 

​

For full details of the topics, including the budget breakdown, read the call text. All documents relating to the call can be found via the Funding and Tenders Portal and the IHI call documents page. You are advised to read these documents, in particular the guide for applicants, carefully.
 

Important information on eligibility for funding

Applicants should note that legal entities based in the following countries are not eligible to receive funding for some of the topics in this call:

Canada and UK: Legal entities are eligible to receive funding under topics 1, 2, 3 and 5, but not eligible to receive funding under topic 4.

Advancing innovation in drug and alcohol addiction healthcare

Funder: Innovate UK

Opened: 16 February 2026

Closes: 11am, 6 May 2026

Sector: Healthcare

This funding is for pharmaceutical, MedTech and digital interventions that can show real world effectiveness and progress towards UK market use. Projects must also secure the regulatory approvals or certificates needed for rollout. By the end of the funded project, innovations should have achieved:

 

  • Technology Readiness Level (TRL) 8 or 9

  • necessary regulatory approvals and certification, or work already underway to get them

  • full market readiness analysis and clear plans for manufacturing and UK rollout

​

If your proposal is technological you must include the design and features of your solution and how it will be applied.

 

This AHG Catalysing Innovation Awards scheme and the funding is split into two strands:

  • CR&D industrial research for industry led R&D projects: grants to support projects with total eligible costs up to an expected £10 million (this strand)

  • Contracts for Innovation for industry led R&D projects: up to an expected £1.5 million funding per project, inclusive of VAT

More information here.

Contracts for Innovation in drug and alcohol addiction healthcare

Funder: Innovate UK

Opened: 16 February 2026

Closes: 11am, 6 May 2026

Sector: Healthcare

​Innovate UK, on behalf of the Office for Life Sciences Addiction Healthcare Goals programme, will award up to 8 SBRI-style contracts (£200,000 to £1.5 million each) as part of a £20 million AHG Catalysing Innovation Awards scheme to develop pharmaceutical, MedTech and digital solutions that improve treatment outcomes, support recovery and reduce harm and deaths from drug and alcohol addiction. Projects can be up to £1 million for MedTech/digital, up to £1.5 million for pharmaceutical solutions. Project start/end: Start 1 October 2026, end by 30 September 2028, up to 24 months’ duration.

​

Aim and scope

Projects must develop addiction-focused pharmaceutical, digital health or MedTech solutions that, by the end of the contract, reach TRL 6–7, show user acceptability and UK market fit, and have a clear plan for IP, regulation, certification and commercialisation. They must address illicit drug or alcohol use (e.g. opioids, stimulants, cannabis, GHB, ketamine, benzodiazepines, gabapentinoids) and target improved treatment outcomes, recovery, or harm and overdose prevention.

​

Proposals must work closely with people with lived experience and treatment or service providers, and engage statutory bodies to map regulatory and adoption pathways. Strong bids will align with the James Lind Alliance addiction priorities, Addiction Healthcare Goals, the UK 10‑year drugs strategy From Harm to Hope and relevant devolved strategies, and show clear commercial potential and UK route to market.

More information here.

​Improving mobility and quality of life after stroke

Funder: NIHR

Opened: 4 December 2025

Closes: 1pm, 6 May 2026

Sector: Healthcare

The  Health Technology Assessment (HTA) Programme is looking to fund research into improving mobility and quality of life after stroke.

​

This is a 2-stage, commissioned funding opportunity. To apply for the first stage you should submit an outline application. If invited to the second stage, you will then need to complete a full application. This is a focused funding opportunity where the intention is to fund a single study.

​

Research question

What is the clinical and cost-effectiveness of interventions to improve mobility on the quality of life of people who have had a stroke?

More information here.

​James Lind Alliance Priority Setting Partnerships rolling funding opportunity

Funder: NIHR

Opened: 8 January 2026

Closes: 1pm, 6 May 2026

Sector: Healthcare & Life Sciences

​​The JLA Priority Setting Partnerships facilitate patients, carers and clinicians to work collaboratively to identify research priorities in particular areas of health and care. 

​

Write a maximum of 5 A4  pages for your research plan. When reviewing applications, NIHR will not consider any additional information over this 5 page limit.
 

Applicants should clearly state how their proposed research addresses a current evidence gap and how the research adds value to the existing NIHR research portfolio.

​

The top 10 priorities (for multiple years and countries) of the JLA priority setting partnerships are shown here. 2025 priorities include:

  • Bone marrow transplantation in paediatrics

  • Burn injury

  • Co-existing dementia and hearing conditions

  • Diverticular disease

  • East London Pandemic PSP for Ethnic Minority Communities

  • Epidermolysis Bullosa

  • Faecal Incontinence in Adults

  • Mental Health and the Body Clock

  • Midwifery Practice and Maternity Care

  • Palliative and End of Life Care Refresh

  • Perianal Crohn’s Disease

  • Prehabilitation for Hip & Knee Replacement Surgery

  • Premature Babies born <25 weeks' gestation

More information here.

NICE rolling funding opportunity

Funder: NIHR

Opened: 8 January 2026

Closes: 1pm, 6 May 2026

Sector: Healthcare & Life Sciences

The Health Technology Assessment Programme (HTA) is inviting outline applications via the commissioned workstream. We are interested in receiving applications to meet recommendations in research identified in NICE guidance that has been published or updated in the last 5 years.   
 

Applications must be within the remit of the HTA Programme, and the primary outcome measure must be health related. The following research programmes are also participating in this funding opportunity: 


After checking the programme remit, you should apply directly to the relevant programme funding opportunity.
 

This is a 2-stage funding opportunity. To apply for the first stage you should submit an outline application. If invited to the second stage, you will then need to complete a full application.

More information here.

Pre-announcement: UKRI Translation: Proof of Concept

Funder: UKRI

Opened: 4 March 2026

Closed: 4pm, 13 May 2026

Sector: All

Apply for funding for research commercialisation activities to develop new products, processes, and services via future venture creation, licensing or other commercialisation routes.
 

Applications are welcomed from any discipline. The programme will not fund discovery or curiosity-driven research.
 

You must be based in a UK research organisation eligible for UK Research and Innovation (UKRI) funding.
 

The full economic cost (FEC) can be up to £250,000 up to nine months duration.
UKRI will fund 80% of the FEC. They aim to support a range of projects across both the cost, length and remit permitted.

More information here.

​Quarterly Research Grant Funding Programme

Funder: Cure Parkinson's

Open: 

Closes: 22 June 2026 

Sector: Healthcare

This scheme is providing grants for scientists and clinicians from universities, hospitals and commercial organisations to help them fund preclinical and clinical research focused on slowing, stopping, or reversing Parkinson’s.

​

There are grants of up to £250,000 which prioritise projects that are likely to lead to clinical trials in people with Parkinson’s within 5 years. For clinical research, CP funds clinical trials and sub-studies of trials in people with Parkinson’s. The grant amount is flexible but please contact CP ahead of submission if you are thinking of applying for a clinical trial.

​

2025/2026 application deadlines:

  • Monday 3 November 2025

  • Monday 12 January 2026

  • Monday 13 April 2026

  • Monday 22 June 2026

  • Monday 12 October 2026

More information here.

Small molecule high throughput screen using AstraZeneca facilities

Funder: MRC

Opened: 30 January 2026

Closes: 4pm, 9 September 2026

Sector: Life Sciences

​Apply for funding to run a high throughput screen (HTS) using AstraZeneca’s compound library and screening robots. There are two funding opportunities per year, which remain open to all targets. 

​

Research Aims

The scheme aims to support discovery of potential starting points for small molecule medicinal drugs against novel targets. AstraZeneca provides technical input for assay optimisation, investigation of alternative readout technologies, and pilot HTS screening before platform transfer. Depending on optimisation results, compound sets of between 100,000 and 1,000,000 molecules will be screened.
 

Thematic Focus

While the opportunity remains open to all targets, this round prioritises mental health or dementia (including Parkinson's and Huntington's disease). Applications in these strategic areas receive ranking uplift during assessment.
 

Lead Organisation Eligibility

Project leads must be based at UK research organisations eligible for MRC funding. Commercial entities cannot lead applications, and collaborations with additional commercial parties are prohibited. International researchers may participate as co-leads or collaborators.

​

Funding and Duration

Projects receive up to £270,000 full economic cost (FEC), with MRC contributing £250,000. Duration typically spans 15 months, ranging from 12 to 18 months. Funding covers: £20,000 (100% FEC) for HTS optimisation and establishment; £150,000 (100% FEC) for HTS execution; travel, accommodation and subsistence for researchers embedding at AstraZeneca for up to three months (80% FEC); screening cascade elements conducted at host organisations (80% FEC); and minimal project lead time (80% FEC). 
More information here.

​

Virtual Human Twin (VHT) Models for Cancer Research

Funder: Horizon Europe 

Opened: 10 February 2026

Closes: 5pm (CET), 15 September 2026

Sector: Healthcare  & Life Sciences

Proposals under this single stage topic should aim to deliver results that are directed and tailored towards and contribute to all of the following expected outcomes:

  • Researchers of different disciplines use advanced multiscale Virtual Human Twins (VHTs) to expand the knowledge and understanding of cancer onset and progression

  • Healthcare professionals and researchers have access to advanced VHT-based solutions that model cancer onset and progression over time, contributing to improve personalised treatments

  • Researchers, healthcare professionals, innovators and citizens have access to cancer VHTs through the UNCAN.eu and the advanced Virtual Human Twin platforms

​

Successful proposals will be asked to join the 'Understanding' project cluster of the EU Cancer Mission and should include a budget for networking, attendance at meetings and joint activities. The Commission will facilitate coordination of this activity. Collaboration is encouraged also with Horizon Europe projects supporting the VHT initiative, as appropriate.

More information here.

Microbiome for early cancer prediction before the onset of disease

Funder: Horizon Europe 

Opened: 10 February 2026

Closes: 5pm (CET), 15 September 2026

Sector: Healthcare & Life Sciences

This single stage topic will contribute to the achievement of the EU Cancer Mission’s objective to achieve better cancer prevention and early detection. The focus is on the development of validated microbiome tools, an assessment of predispositions, the comparison with other predictive tools and risk modelling approaches.

​

Proposals should address all of the following:

  • Development of microbiome tools for earlier, better and personalised prediction and prevention of cancer before the onset of the disease; if possible 2 years before the onset of the disease. Proposals should deal with several types of cancer if possible.

  • Assessments of predispositions, AI risk modelling approaches and organ/body simulations.

  • Collaboration with large cohorts/registries from different communities, usage of existing microbiome and clinical data in combination with and generation of new data. These data could include other predictive signs such as sensations of fatigue, unusual pain, weight loss or other body changes.

  • Citizen engagement could be included with data and sample collections as well as educational programmes.

  • Comparison with other minimally invasive liquid biopsy and other tests concerning their predictive power, simplicity, cost-benefits and potential for commercialisation.

  • Validation of the tests in an independent cohort. Development of guidelines that help to manage risk factors such as lifestyle or diet. The outcome and expertise of ongoing EU and International initatives and the International Cancer Microbiome Consortium could be considered for the reliability of the tests and guidelines to be developed. Age, sex and gender differences should be duly considered.

More information here.

European Partnership on Rare Diseases

Funder: Horizon Europe

Opened: 10 February 2026

Closes: 5pm (CET), 15 September 2026

Sector: Healthcare & Life Sciences

This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination “Tackling diseases and reducing disease burden”. To that end, proposals under this topic should aim to deliver results that are directed at, tailored towards and contributing to all the following expected outcomes:

  • The EU is reinforced as an internationally recognised driver of research and innovation in Rare Diseases (RD) and thereby substantially contributing to the achievement of the Sustainable Development Goals related to rare diseases.

  • Research funders align, adopt and implement their RD research policies allowing for the optimal generation and translation of knowledge into meaningful health products and interventions responding to the needs of people living with a rare disease across Europe and globally.

  • The RD research community at large benefit from and use an improved comprehensive knowledge framework and cross-border FAIR[1] data access and analysis, including rare diseases registries, by integrating the EU, national/regional data and information infrastructures to improve translational research.

  • People living with a rare disease, including those from underrepresented communities, benefit from a more timely, equitable access to innovative, sustainable and high-quality healthcare including novel diagnosis and treatments, taking stock of highly integrated research and healthcare systems.

  • Researchers, innovators -as well as people living with a rare disease and their advocates (as co-creators)- effectively constitute and operate into an integrated research and innovation ecosystem to deliver cost-effective diagnosis and treatments.

  • Public and private actors, including civil society (e.g. Non-Governmental Organisations, charities), establish coordinated and efficient multi-stakeholder collaborations at EU and national (including regional) levels, allowing for more effective clinical research, for example aiming at improved success rates of therapeutic development.

More information here.
 

The total indicative budget for the topic is EUR 91.3 million committed in annual instalments over the two years, 2026 and 2027 (EUR 48.7 million from the 2026 budget and EUR 42.6 million from the 2027 budget).

​Quarterly Research Grant Funding Programme

Funder: Cure Parkinson's

Open: 

Closes: 12 October 2026 

Sector: Healthcare

This scheme is providing grants for scientists and clinicians from universities, hospitals and commercial organisations to help them fund preclinical and clinical research focused on slowing, stopping, or reversing Parkinson’s.

​

There are grants of up to £250,000 which prioritise projects that are likely to lead to clinical trials in people with Parkinson’s within 5 years. For clinical research, CP funds clinical trials and sub-studies of trials in people with Parkinson’s. The grant amount is flexible but please contact CP ahead of submission if you are thinking of applying for a clinical trial.

​

2025/2026 application deadlines:

  • Monday 3 November 2025

  • Monday 12 January 2026

  • Monday 13 April 2026

  • Monday 22 June 2026

  • Monday 12 October 2026

More information here.

Public Health Research Programme Rapid Funding Scheme

Funder: NIHR

Opened: 16 December 2025

Closes: 16 December 2026

Sector: Healthcare

The Public Health Research (PHR) Programme funds research to generate evidence to inform the delivery of non-NHS interventions, intended to improve the health of the public, and reduce inequalities in health.
 

The Rapid Funding Scheme (RFS) was launched in March 2018 and offers researchers the opportunity to apply for funds to conduct rapid baseline data collection, as well as other feasibility work, prior to intervention implementation, for unique, time-limited opportunities such as a natural experiment or similar evaluations of a new public health intervention. 
 

This scheme is not intended to fund studies which provide definitive answers to questions to inform service provision – it is to prepare for such studies.

​

Funding is a maximum of £50,000 for a duration of 6 months.

​

More information here.

AI Futures Fund

Funder: Google

Ongoing

Sector: ALL

Google has launched its AI Futures Fund, a new initiative that seeks to invest in startups that are building with the latest AI tools from Google DeepMind, the company’s AI R&D lab. 

​

The fund will back startups from seed to late stage and will offer varying degrees of support, including allowing founders to have early access to Google AI models from DeepMind, the ability to work with Google experts from DeepMind and Google Labs, and Google Cloud credits. Some startups will also have the opportunity to receive direct investment from Google. 

​

“The AI Futures Fund doesn’t follow a batch or cohort model,” a Google spokesperson told TechCrunch. “Instead, we consider opportunities on a rolling basis - there’s no fixed application window or deadline. When we come across companies that align with the fund’s thesis, we may choose to invest. We’re not announcing a specific fund size at this time, and check sizes vary based on the company’s stage and needs - typically early to mid-stage, with flexibility for later-stage opportunities as well.”

More information here.

Apply here.

Rolling opportunity seeds

Funder: ARIA

Ongoing

Sector: Mathematics for Safe AI

Breakthroughs require finding people who think differently about what’s possible – and empowering them to follow their vision.   To support scientific and technological breakthroughs, ARIA Programme Directors can award funding to small but highly ambitious projects, “opportunity seeds”, to support ambitious research aligned to their opportunity spaces. To understand how opportunity seeds work within ARIA's broader funding model and complement its programme funding, see ARIA's research model.  

For opportunity seed projects, ARIA's Programme Directors are looking for bold ideas that could change the conversation about what is possible or valuable and provide steps towards new capabilities. If you have an important idea you’re obsessed with, but you don’t currently have the resources or support to take it forward, ARIA would like to hear from you. Ideas could come from anywhere, so they welcome proposals from individuals and teams who are early in their career or who have atypical backgrounds. They care more about your idea and your intrinsic motivation than they do about your CV. 

More information here.

Impact in Healthcare Fund

Funder: Peter Sowerby Foundation

Ongoing

Sector: Healthcare

Initial discussions with prospective organisations will take place before an invitation to submit a formal application is made. If you believe that you have an idea for a project that is closely aligned with the Foundation's  aims and recent grants, please submit a brief synopsis, including a summary budget and proposed timeline, using the form here. The Foundation cannot respond to all the ideas it is sent, but they do read all proposals and get in touch with those they feel could be a good fit.

​

The Foundation is currently seeking to fund projects which:

  • Tackle a clear and demonstrable need* across a range of health condition 

AND

  • Are proven to be impactful and where additional funds could EITHER increase the scale or depth of impact OR sustain projects ‘at risk’.
     

The Foundation will prioritise applications which focus on:

  • outreach and delivery in the community, as opposed to formal healthcare settings OR

  • work with a digital or data focus OR

  • preventative health care to improve patient well-being. 

​

The Foundation is seeking projects where:

  • there is clear evidence of the need for a specific health intervention OR

  • there is a gap in the availability of treatment or support OR

  • the quality of support available is not up to a required standard.

Applicants may look to evidence need in different ways. This might include empirical evidence, academic or sector-led research or consultation (for example, with beneficiary groups or health professionals).

​

There are two strands of grants:

​

Grant 1

Grants of up to £500,000, potentially over multiple years - for projects which are (projects must fit all of the below):

  • proven 

  • ready to scale 

  • run by organisations with compelling track records and an established leadership team.

  • backed by clear evidence of need.

  • sustainable in the long-term following the Foundation’s investment.

​

Grant 2

Substantial Grants ~£2-3million over multiple years.

From time to time, the Foundation will invite organisations to develop projects which are impactful in a specific area of the Foundation’s interest, and which align with the aims and objectives of the Impact in Healthcare Fund.

It is envisaged that funds could be spent in a range of different ways for example:

  • supporting infrastructure OR

  • core staffing posts OR

  • existing impactful initiatives and which could be sustained over a long-term period thanks to funds from the Foundation OR

  • scale-up of pilot activities which show proven impact OR

  • other means suggested by the applicant.

Impact Jersey Innovation Programme

Funder: Impact Jersey

Open

Closes:  Ongoing

Sector: Healthcare

Whether you’re developing a pilot, a proof of concept, or a scalable solution, the programme offers:

  • Applications open all year round

  • Flexible funding aligned to Jersey’s strategic priorities

  • 1-to-1 support to shape stronger proposals

From application guidelines to funding info and FAQs, everything you need is now live on the application page.

​

Up to £500,000 will be available per quarter (with a maximum of £1 million available in 2025 and £2 million during 2026).

Impact Jersey focuses on funding a range of technology solutions to key issues and addressing strategic priorities defined by the Government of Jersey. To delve deeper into Ministerial Priorities click on pages 6 & 7 of the Impact Jersey Strategic Programme Proposal.

​

Key health ones are:

  • Ageing Population - How can we help people live independently for longer?

  • Health & Wellbeing - How can we monitor and identify hazards to health and provide interventions at the earliest opportunity?

​

Global Innovation Fund- Grants

Funder: Global Innovation Fund

Open, no closing date

Sector: All

The Global Innovation Fund is a non-profit, impact-first investment fund headquartered in London with offices in Washington, D.C. and Nairobi. It invests in the development, rigorous testing, and scaling up of new products, services, business process, or policy reforms that are more cost-effective than current practice and targeted at improving the lives of the world's poorest people.

​

It accepts applications from organisations working in any sector in any developing country. Any type of organisation may apply. This includes social enterprises, for-profit companies, non-profit organisations, government agencies, international organisations, and research institutions in any country. It is recommended that individual innovators, entrepreneurs, or researchers apply through an affiliated organisation. 

More information.

Big Ideas

Funder: CW+

Open, no closing date

Sector: Healthcare & Life Sciences

If you're an employee of Chelsea and Westminster Hospital NHS Foundation Trust, then you can apply for this grant.

​

The programme is designed to: promote innovation, transformation and new service development; support staff in the delivery of front line patient care. Awards are usually up to £50,000.
More information here.

Pre-Seed Challenge Fund

Funder: Lyva Labs

Ongoing

Sector: Healthcare & Life Sciences

Businesses and start-ups working in the Diagnostics/Med Tech/Health Tech/Digital Health space can apply for funding to support idea development and commercialisation.Innovative businesses and start-ups across the region (Liverpool City) can apply for investment of £25,000 to £250,000 for idea development and commercialisation. Total fund of £6m. Businesses must be based or willing to relocate to Liverpool City Region.

More information here.

Catapult/RTO Grants

Funder: Innovate UK Business Growth

Open, no closing date

Sector: All

Up to £15,000 grants available for:

  • Sector specific advice on expertise;

  • Testing and/or development work;

  • Market analysis, cost modelling etc;

  • Identifying opportunities for R&D, partnership building & collaboration, and more.

More information.​

Past Funding Calls can be viewed using the links below:
2026
2025
2024
bottom of page